Venture Partner - Utah

Michael Paul, Ph.D.
CEO of LineaGen Partners, (Genetics Population Database) and its Respiris spin-off
Formerly with NPS Pharmaceuticals as Director, Strategic Development
Named to v/Spring Capital’s v/100 list in 2005
Former Utah Tech Transfer Office intern
Registered to practice before U.S. Patent Office
Ph.D. Biochemistry and Molecular Biology from the University of Utah
